PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE II GRANT
PneumoNIX has received follow-on Phase II grant from the NSF SBIR to continue the development of their proprietary technology.
top of page
PnemoNIX in the News
- Nov 10, 2019
PNEUMONIX MEDICAL RECEIVES NSF SBIR PHASE I GRANT
PneumoNIX Medical, a Baltimore-based medtech company focused on preventing complications associated with soft tissue biopsies, announced...
- May 7, 2019
PNEUMONIX MEDICAL ENDORSED BY JOHNS HOPKINS LUNG CANCER SCREENING INITIATIVE
PneumoNIX Medical was selected to present to Johns Hopkins Hospital, Maryland Department of Commerce and Technology Development...
- Apr 24, 2019
PNEUMONIX SELECTED TO PRESENT AT 2019 ANGEL CAPITAL ASSOCIATION INNOVATION SHOWCASE
PneumoNIX Medical is 1 of 50 startups nationwide selected to present to the nations top angel investors. The showcase features the most...
- Mar 15, 2019
PNEUMONIX ATTENDS ASPIRE INVESTOR READINESS PROGRAM THROUGH VENTUREWELL
PneumoNIX was selected as 1 of 15 MedTech start-ups to attend VentureWell’s investor readiness program. The program ensures the companies...
- Feb 1, 2019
PNEUMONIX AWARDED MARYLAND INDUSTRIAL PARTNERSHIPS PROGRAM PHASE I GRANT
Read more about it.
- Nov 26, 2018
PNEUMONIX WINS VENTUREWELL E-TEAM PHASE II GRANT FOR PREVENTING PTX
Meet PneumoNIX team at the VentureWell E-team workshop in Boston from Jan. 31st - Feb. 2nd Read more about it.
- Aug 2, 2018
PNEUMONIX MEDICAL AWARDED THE CIGARETTE RESTITUTION FUND GRANT BY STATE OF MARYLAND
Cigarette Restitution Fund
- Jul 15, 2018
PNEUMONIX AWARDED THE JOHNS HOPKINS TECH ACCELERATOR FUND GRANT
Read more about the Technology Accelerator Fund.
- Jul 13, 2018
- Jun 12, 2018
PNEUMONIX WINS VENTUREWELL E-TEAM PHASE I GRANT
Read more about it.
bottom of page